Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker syndrome?

Enrico Nastro Siniscalchi; Giovanni Raffa

doi:10.4081/vl.2023.12088

Authors

Enrico Nastro Siniscalchi Division of Maxillofacial Surgery, BIOMORF Department, University of Messina, Italy, Italy. https://orcid.org/0000-0002-4424-0917
Giovanni Raffa
giovanni.raffa@unime.it
Division of Neurosurgery, BIOMORF Department, University of Messina, Italy. https://orcid.org/0000-0001-8623-4964

Not available.

Angelini C, Mantovani G, Cavallo MA, et al. Neurosurgical implications of the Jugular Vein Nutcracker. Veins and Lymphatics. 2023;12:11892. DOI: https://doi.org/10.4081/vl.2023.11892

Siniscalchi EN, Raffa G, Germano A, De Ponte FS. Is Eagle jugular syndrome an underestimated potentially life-threatening disease? The Canadian journal of neurological sciences Le Journal Canadien des Sciences Neurologiques. 2020:1-5.

Dashti SR, Nakaji P, Hu YC, et al. Styloidogenic jugular venous compression syndrome: diagnosis and treatment: case report. Neurosurgery. 2012;70:E795-9. DOI: https://doi.org/10.1227/NEU.0b013e3182333859

Scerrati A, De Bonis P, Zamboni P, et al. A New Insight in Nonaneurysmal Subarachnoid Hemorrhage: The Potential Role of the Internal Jugular Veins. J Neurol Surg A Cent Eur Neurosurg. 2022;83:344-50. DOI: https://doi.org/10.1055/s-0041-1733895

Martinelli I. Unusual forms of venous thrombosis and thrombophilia. Pathophysiology of haemostasis and thrombosis. 2002;32:343-5. DOI: https://doi.org/10.1159/000073595

Ten Cate V, Rapp S, Schulz A, et al. Circulating microRNAs predict recurrence and death following venous thromboembolism. J Thromb Haemost. 2023;21:2797-810. DOI: https://doi.org/10.1016/j.jtha.2023.07.010

Nastro Siniscalchi, E., & Raffa, G. (2023). Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker syndrome?. Veins and Lymphatics, 12(1). https://doi.org/10.4081/vl.2023.12088